Editas Medicine, Inc. (LON:0IFK)

Editas Medicine Revenue

Editas Medicine had revenue of $7.54M USD in the quarter ending September 30, 2025, with 12,265.57% growth. This brings the company's revenue in the last twelve months to $46.38M, down -24.90% year-over-year. In the year 2024, Editas Medicine had annual revenue of $32.31M, down -58.64%.

• Revenue (ttm): $46.38M
• Revenue Growth: -24.90%
• P/S Ratio: 3.67
• Revenue / Employee: $188.55K
• Employees: 246
• Market Cap: 126.64M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.31M	-45.81M	-58.64%
Dec 31, 2023	78.12M	58.41M	296.32%
Dec 31, 2022	19.71M	-5.83M	-22.83%
Dec 31, 2021	25.54M	-65.19M	-71.85%
Dec 31, 2020	90.73M	70.20M	341.93%
Dec 31, 2019	20.53M	-11.41M	-35.71%
Dec 31, 2018	31.94M	18.21M	132.64%
Dec 31, 2017	13.73M	7.68M	126.80%
Dec 31, 2016	6.05M	4.42M	271.58%
Dec 31, 2015	1.63M	-	-
Dec 31, 2014	-	-	-